Abstract:Background: Diabetic foot ulcers (DFUs) pose a significant risk for individuals with long-standing diabetes mellitus, leading to hospitalizations and potential amputations. The prevalence of diabetes in India is expected to reach 57 million by 2025. DFUs are resolvable complications, with proper treatment resulting in healing rates of 75–80%, while a percentage of cases may require amputations. Effective management requires a multidisciplinary approach, including sterile dressing, meticulous foot care, and appropriate antibiotic therapy. The irrational use of antibiotics, often based on random choices before obtaining culture reports, contributes to the burden. DFUs impact the quality of life, exacerbate the economic burden, and affect low socioeconomic groups disproportionately. This study proposes an antibiotic policy to reduce irrational antibiotic use until sample reports are available, promoting more rational prescribing practices. Aim and Objectives: The aim of the study was (i) to identify commonly infecting organisms in DFU cases; (ii) to look for the prevalence of antimicrobial resistance in cases of DFU; and (iii) to come up with a disease and region-specific antibiogram. Materials and Methods: The culture and sensitivity reports of DFU swabs were retrospectively procured from multiple microbiology labs between September 2018 and September 2019. The data collected were tabulated into Excel worksheet and analyzed. The results were then simplified into pie and bar charts. Many descriptive statistical tools such as percentage and mean were used to come to a conclusion. Results: 159 cases of DFUs were examined, revealing that 81% of cases occurred in men and the incidence increased with age, with 65% of cases being over the age of 50 years. Staphylococcus aureus was the most common infecting organism (20.75%), followed by Klebsiella, Escherichia coli, and Pseudomonas. Non-healing ulcers in 9.7% of cases showed no bacterial growth. Amikacin exhibited the highest sensitivity (60%), whereas ceftazidime demonstrated the highest resistance (66%). Over 80% of patients had long-standing diabetes for over 15 years. Conclusion: The study highlights the prevalence of antibiotic-resistant organisms and the need for a well-defined antibiotic protocol. Uncontrolled diabetes increases the risk of DFUs. Empirical antibiotic treatment is crucial before culture reports, and amikacin, cefazolin, and vancomycin combination therapy is effective. Ceftazidime, amoxicillin/clavulunate, and cefotaxime should be avoided. The patient education on foot care is vital.

Antibiotic Treatment Practices and Microbial Profile in Diabetic Foot Ulcers: A Retrospective Cohort Study

Bacteriological profile and antibiotic sensitivity pattern in diabetic foot ulcer: A retrospective study

Prospective Observational Study of Microbiology of Infected Diabetic Foot Ulcers in a Tertiary-Care Hospital

Empirical Antibiotic Treatment In Diabetic Foot Infection: A Study Focusing On The Culture And Antibiotic Sensitivity In A Population From Southern China

The Profile of Microbiological Pathogens in Diabetic Foot Ulcers

Risk Factors for Multidrug-Resistant Bacterial Infection in Diabetic Foot Ulcers

The antimicrobial susceptibility patterns of diabetic foot ulcers in the South African public healthcare sector

Clinical and bacteriological profile of diabetic foot infections in a tertiary care

A study on diabetic foot ulcers in Central rural India to formulate empiric antimicrobial therapy

Diabetic foot ulcer-a systematic review on relevant microbial etiology and antibiotic resistance in Asian countries

Microbiological Distribution, Antimicrobial Susceptibility and Risk Factors of Polymicrobial Infections in Diabetic Foot

The Microbial Diversity and Antimicrobial Susceptibility Profile Underlying Diabetic Foot Osteomyelitis: A Retrospective Study Conducted in North Queensland, Australia

Microbial Infection and Antibiotic Susceptibility of Diabetic Foot Ulcer in China: Literature Review

Predictors of Successful Antibiotic Treatment of Osteomyelitis in Diabetic Forefoot Infection

Antibiotic Resistance Profiles of Extended-Spectrum β-Lactamase (ESBL)- and Metallo-β-Lactamase (MBL)-Producing Klebsiella pneumoniae Isolates From Diabetic Foot Ulcers: Implications for Treatment Strategies

Microbial spectrum, antibiotic susceptibility profile, and biofilm formation of diabetic foot infections (2014–18): a retrospective multicenter analysis

Bacterial profile and antimicrobial resistance patterns of infected diabetic foot ulcers in sub-Saharan Africa: a systematic review and meta-analysis

Optimizing Antibiotic Treatment for Diabetic Foot Infections: A Study From a Tertiary Public Healthcare Center in Puducherry, South India

Antimicrobial Remedies and Emerging Strategies for the Treatment of Diabetic Foot Ulcers

Pattern and microbiological characteristics of diabetic foot ulcers in a Nigerian tertiary hospital

Insight into multidrug-resistant microorganisms from microbial infected diabetic foot ulcers